跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gal-100
首页
药物
Gal-100
Gal-100
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PROCESS FOR SYNTHESIZING A FORMULATION OF GALANGIN-LOADED HYDROGEL FOR EXPEDITED WOUND HEALING
申请人: ALKINANI KHADIJAH B
优先权: 2025
US
Pharmaceutical composition for preventing and treating AD and application thereof
申请人: UNIV HEILONGJIANG CHINESE MEDICINE
优先权: 2020
CN
一种用于防治AD的药物组合物及其应用
申请人: 黑龙江中医药大学
优先权: 2024
CN
Application of acellular extracellular matrix in preparation of anti-vascular aging product
申请人: PEKING UNIV SHENZHEN HOSPITAL PEKING UNIV SHENZHEN CLINIC MEDICAL COLLEGE
优先权: 2026
CN
Acidic clerodendranthus spicatus polysaccharide as well as preparation method and application thereof
申请人: UNIV YUNNAN TRADITIONAL CHINESE MEDICINE
优先权: 2024
CN
种鹿角海萝多糖
申请人: 汕头大学医学院
优先权: 2015
CN
Cell anti-aging essence and preparation method thereof
申请人: GUANGZHOU SHAAI BIOLOGICAL TECH CO LTD
优先权: 2022
CN
Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
申请人: BORUNDA JUAN ARMENDARIZ
优先权: 2000
US
药物
反馈